These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

455 related items for PubMed ID: 30888584

  • 1. Cholecalciferol supplementation increases FGF23 in peritoneal dialysis patients with hypovitaminosis D: a randomized clinical trial.
    Ramirez-Sandoval JC, Arvizu-Hernandez M, Cruz C, Vazquez-Cantu B, Rojas-Concha LJ, Tamez L, Reynerio F, Gomez FE, Correa-Rotter R.
    J Nephrol; 2019 Aug; 32(4):645-659. PubMed ID: 30888584
    [Abstract] [Full Text] [Related]

  • 2. Effect of 16-weeks vitamin D replacement on calcium-phosphate homeostasis in overweight and obese adults.
    Mesinovic J, Mousa A, Wilson K, Scragg R, Plebanski M, de Courten M, Scott D, Naderpoor N, de Courten B.
    J Steroid Biochem Mol Biol; 2019 Feb; 186():169-175. PubMed ID: 30367939
    [Abstract] [Full Text] [Related]

  • 3. The Effect of Long-Term Cholecalciferol Supplementation on Vascular Calcification in Chronic Kidney Disease Patients With Hypovitaminosis D.
    Samaan F, Carvalho AB, Pillar R, Rocha LA, Cassiolato JL, Cuppari L, Canziani MEF.
    J Ren Nutr; 2019 Sep; 29(5):407-415. PubMed ID: 30686750
    [Abstract] [Full Text] [Related]

  • 4. Impact of cholecalciferol treatment on biomarkers of inflammation and myocardial structure in hemodialysis patients without hyperparathyroidism.
    Bucharles S, Barberato SH, Stinghen AEM, Gruber B, Piekala L, Dambiski AC, Custodio MR, Pecoits-Filho R.
    J Ren Nutr; 2012 Mar; 22(2):284-291. PubMed ID: 21908203
    [Abstract] [Full Text] [Related]

  • 5. Cholecalciferol (vitamin D3) therapy and vitamin D insufficiency in patients with chronic kidney disease: a randomized controlled pilot study.
    Chandra P, Binongo JN, Ziegler TR, Schlanger LE, Wang W, Someren JT, Tangpricha V.
    Endocr Pract; 2008 Mar; 14(1):10-7. PubMed ID: 18238736
    [Abstract] [Full Text] [Related]

  • 6. High-dose cholecalciferol reduces parathyroid hormone in patients with early chronic kidney disease: a pilot, randomized, double-blind, placebo-controlled trial.
    Alvarez JA, Law J, Coakley KE, Zughaier SM, Hao L, Shahid Salles K, Wasse H, Gutiérrez OM, Ziegler TR, Tangpricha V.
    Am J Clin Nutr; 2012 Sep; 96(3):672-9. PubMed ID: 22854402
    [Abstract] [Full Text] [Related]

  • 7. The impact of cholecalciferol on markers of vascular calcification in hemodialysis patients: A randomized placebo controlled study.
    Alshahawey M, El Borolossy R, El Wakeel L, Elsaid T, Sabri NA.
    Nutr Metab Cardiovasc Dis; 2021 Feb 08; 31(2):626-633. PubMed ID: 33594986
    [Abstract] [Full Text] [Related]

  • 8. Effect of cholecalciferol recommended daily allowances on vitamin D status and fibroblast growth factor-23: an observational study in acute burn patients.
    Rousseau AF, Damas P, Ledoux D, Cavalier E.
    Burns; 2014 Aug 08; 40(5):865-70. PubMed ID: 24462294
    [Abstract] [Full Text] [Related]

  • 9. Fibroblast growth factor 23 and parathyroid hormone after treatment with active vitamin D and sevelamer carbonate in patients with chronic kidney disease stage 3b, a randomized crossover trial.
    Bleskestad IH, Bergrem H, Hartmann A, Godang K, Gøransson LG.
    BMC Nephrol; 2012 Jun 28; 13():49. PubMed ID: 22742720
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of body weight-adapted oral cholecalciferol substitution in dialysis patients with vitamin D deficiency.
    Zitt E, Sprenger-Mähr H, Mündle M, Lhotta K.
    BMC Nephrol; 2015 Aug 04; 16():128. PubMed ID: 26238347
    [Abstract] [Full Text] [Related]

  • 11. Effect of Cholecalciferol therapy on serum FGF23 in vitamin D deficient patients: a randomized clinical trial.
    Kamelian T, Saki F, Jeddi M, Dabbaghmanesh MH, Omrani GHR.
    J Endocrinol Invest; 2018 Mar 04; 41(3):299-306. PubMed ID: 28795342
    [Abstract] [Full Text] [Related]

  • 12. Pattern of 25-hydroxy vitamin D response at short (2 month) and long (1 year) interval after 8 weeks of oral supplementation with cholecalciferol in Asian Indians with chronic hypovitaminosis D.
    Goswami R, Gupta N, Ray D, Singh N, Tomar N.
    Br J Nutr; 2008 Sep 04; 100(3):526-9. PubMed ID: 18252022
    [Abstract] [Full Text] [Related]

  • 13. Effects of cholecalciferol on functional, biochemical, vascular, and quality of life outcomes in hemodialysis patients.
    Hewitt NA, O'Connor AA, O'Shaughnessy DV, Elder GJ.
    Clin J Am Soc Nephrol; 2013 Jul 04; 8(7):1143-9. PubMed ID: 23493381
    [Abstract] [Full Text] [Related]

  • 14. Effect of cholecalciferol on vitamin D-regulatory proteins in monocytes and on inflammatory markers in dialysis patients: A randomized controlled trial.
    Meireles MS, Kamimura MA, Dalboni MA, Giffoni de Carvalho JT, Aoike DT, Cuppari L.
    Clin Nutr; 2016 Dec 04; 35(6):1251-1258. PubMed ID: 27161894
    [Abstract] [Full Text] [Related]

  • 15. Effects of High-Dose Vitamin D2 Versus D3 on Total and Free 25-Hydroxyvitamin D and Markers of Calcium Balance.
    Shieh A, Chun RF, Ma C, Witzel S, Meyer B, Rafison B, Swinkels L, Huijs T, Pepkowitz S, Holmquist B, Hewison M, Adams JS.
    J Clin Endocrinol Metab; 2016 Aug 04; 101(8):3070-8. PubMed ID: 27192696
    [Abstract] [Full Text] [Related]

  • 16. The Effects of Cholecalciferol Supplementation on FGF23 and α-Klotho in Hemodialysis Patients With Hypovitaminosis D: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Etemadi J, Samadifar M, Ghojazadeh M, Motavalli R, Oriyo R, Majidi T, Tayebi Khosroshahi H.
    J Ren Nutr; 2022 May 04; 32(3):334-340. PubMed ID: 34294550
    [Abstract] [Full Text] [Related]

  • 17. The Effect of Vitamin D Supplementation on Bone Metabolic Markers in Chronic Kidney Disease.
    Yadav AK, Kumar V, Kumar V, Banerjee D, Gupta KL, Jha V.
    J Bone Miner Res; 2018 Mar 04; 33(3):404-409. PubMed ID: 29044707
    [Abstract] [Full Text] [Related]

  • 18. Vitamin D₃supplementation in Batswana children and adults with HIV: a pilot double blind randomized controlled trial.
    Steenhoff AP, Schall JI, Samuel J, Seme B, Marape M, Ratshaa B, Goercke I, Tolle M, Nnyepi MS, Mazhani L, Zemel BS, Rutstein RM, Stallings VA.
    PLoS One; 2015 Mar 04; 10(2):e0117123. PubMed ID: 25706751
    [Abstract] [Full Text] [Related]

  • 19. Use of Extended-Release Calcifediol to Treat Secondary Hyperparathyroidism in Stages 3 and 4 Chronic Kidney Disease.
    Sprague SM, Crawford PW, Melnick JZ, Strugnell SA, Ali S, Mangoo-Karim R, Lee S, Petkovich PM, Bishop CW.
    Am J Nephrol; 2016 Mar 04; 44(4):316-325. PubMed ID: 27676085
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of a short course of very-high-dose cholecalciferol in hemodialysis.
    Wasse H, Huang R, Long Q, Singapuri S, Raggi P, Tangpricha V.
    Am J Clin Nutr; 2012 Feb 04; 95(2):522-8. PubMed ID: 22237061
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.